Royalty Pharma plc SEC filings RPRX
Royalty Pharma plc has 635 filings in SEC EDGAR's recent list, going back to Feb 13, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 10, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 11, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 11, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 12, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 15, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 15, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 15, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 24, 2021 | Dec 31, 2020 |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RPRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1802768
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.